Jan-Dirk Vermeij
Overview
Explore the profile of Jan-Dirk Vermeij including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
693
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Westendorp W, Vermeij J, Smith C, Kishore A, Hodsoll J, Kalra L, et al.
Eur Stroke J
. 2022 Mar;
6(4):385-394.
PMID: 35342808
Introduction: Infection after stroke is associated with unfavorable outcome. Randomized controlled studies did not show benefit of preventive antibiotics in stroke but lacked power for subgroup analyses. Aim of this...
2.
Haak B, Westendorp W, van Engelen T, Brands X, Brouwer M, Vermeij J, et al.
Transl Stroke Res
. 2020 Oct;
12(4):581-592.
PMID: 33052545
In recent years, preclinical studies have illustrated the potential role of intestinal bacterial composition in the risk of stroke and post-stroke infections. The results of these studies suggest that bacteria...
3.
Verschoof M, Groot A, Vermeij J, Westendorp W, van den Berg S, Nederkoorn P, et al.
Stroke
. 2019 Nov;
51(1):338-341.
PMID: 31665992
Background and Purpose- Low blood pressure is uncommon in patients with acute ischemic stroke (AIS). We assessed the association between baseline low blood pressure and outcomes in patients with AIS....
4.
Vermeij J, Westendorp W, van de Beek D, Nederkoorn P
Int J Stroke
. 2018 Sep;
13(9):913-920.
PMID: 30175940
This review provides an update of evidence on post-stroke infections and the use of preventive antibiotics in stroke. Infection is a common complication after stroke, affecting between 15% and 30%...
5.
Westendorp W, Vermeij J, Hilkens N, Brouwer M, Algra A, van der Worp H, et al.
Eur Stroke J
. 2018 Jun;
3(2):136-144.
PMID: 29900413
Introduction: Patients with acute stroke are at high risk for infection. These infections are associated with unfavourable outcome after stroke. A prediction rule can identify the patients at the highest...
6.
Westendorp W, Zock E, Vermeij J, Kerkhoff H, Nederkoorn P, Dijkgraaf M, et al.
Neurology
. 2018 Apr;
90(18):e1553-e1560.
PMID: 29626176
Objective: To evaluate the cost-effectiveness of preventive ceftriaxone vs standard stroke unit care without preventive antimicrobial therapy in acute stroke patients. Methods: In this multicenter, randomized, open-label trial with masked...
7.
van Dijk T, Vermeij J, van Koningsbruggen S, Lakeman P, Baas F, Poll-The B
J Inherit Metab Dis
. 2018 Feb;
41(5):897-898.
PMID: 29464431
Mutations in the SEPSECS gene are associated with pontocerebellar hypoplasia type 2D. Pontocerebellar hypoplasia (PCH) is a heterogeneous group of rare autosomal recessive neurodegenerative disorders, mainly affecting pons and cerebellum....
8.
Vermeij J, Westendorp W, Dippel D, van de Beek D, Nederkoorn P
Cochrane Database Syst Rev
. 2018 Jan;
1:CD008530.
PMID: 29355906
Background: Stroke is the main cause of disability in high-income countries and ranks second as a cause of death worldwide. Infections occur frequently after stroke and may adversely affect outcome....
9.
Westendorp W, Vermeij J, Brouwer M, Roos Y, Nederkoorn P, van de Beek D
Cerebrovasc Dis
. 2016 Oct;
42(5-6):506-511.
PMID: 27701170
Background: Stroke-associated infections occur frequently and are associated with unfavorable outcome. Previous cohort studies suggest a protective effect of beta-blockers (BBs) against infections. A sympathetic drive may increase immune suppression...
10.
Vermeij J, Westendorp W, Roos Y, Brouwer M, van de Beek D, Nederkoorn P
Cerebrovasc Dis
. 2016 Jun;
42(5-6):361-369.
PMID: 27336314
Background: The Preventive Antibiotics in Stroke Study (PASS), a randomized open-label masked endpoint trial, showed that preventive ceftriaxone did not improve functional outcome at 3 months in patients with acute...